₹1429.3
+2.28% today
· 30d +8.44%
as of 2026-11-09
Price · Daily Candles
“Medanta shines in profitability, but FIIs pare holdings as DIIs step up.”
Global Health (Medanta) recorded strong quarterly growth with net profit up 39.73% YoY to ₹142 Cr and revenue increasing by 24.46% YoY to ₹1,159 Cr in Q4 2026. The company maintains its 'Strong' growth and 'High' profitability scores, yet FII holdings decreased by 0.38% QoQ, coinciding with a 0.76% increase from DIIs.
BULL CASE
+Q4 2026 net profit surged +39.73% YoY to ₹142 Cr, outperforming revenue growth.
+Quarterly revenue saw a significant increase of +24.46% YoY, reaching ₹1,159 Cr.
+Annual net profit CAGR for the last 5 years stands at an impressive 80.62%, indicating strong sustained growth.
+The company boasts high profitability with a TTM profit margin of 12.62% and ROCE of 17.0%.
BEAR CASE
−Free cash flow remains negative at -₹124 Cr, resulting in a -0.37% FCF yield.
−FIIs reduced their stake by 0.38% QoQ, bringing their total holding to 10.15%.
−Operating profit margin declined by 2.49% YoY in Q4 2026, despite revenue growth.
−The share price is 15.7% off its 52-week high of ₹1456.5, trading at ₹1227.9.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹1469 Cr
+33.64% YoY
NET PROFIT
₹219 Cr
+38.35% YoY
OPM
26.38%
+3.97pp YoY
EPS
₹8.21
PE 59.62
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-0.3% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
With a TTM PE of 59.62 and ROCE of 17.0%, Medanta trades at a more attractive valuation than peers like Apollo Hospitals (PE 82.13, ROCE 20.26%) and Fortis (PE 94.26, ROCE 13.4%), while offering a better ROCE than Max Healthcare (ROCE 14.44%).
PEERPEROCE %
MEDANTA59.6217.0
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
64
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
75
Valuation
STRETCHED
20
Growth
STRONG
73
Profitability
HIGH
85
Technicals
NEUTRAL
58
Risk
LOW
70
Key Stats
TTM PE
59.62
P/B
8.92
52W HIGH
₹1544.0
OFF HIGH
-7.43%
DIV YIELD
0.04%
MKT CAP
₹38436 Cr
◉ Active Signals
MACDBullish24.5201
RSI(14)Bullish63.93
Street Consensus
17 analysts₹1419.06
mean target
Low ₹1210.0Now ₹1429.3High ₹1570.0
⧉ Strategy Fit 🔒